UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000047095
Receipt No. R000053718
Scientific Title Outcomes of continuous renal replacement therapy: a multicenter retrospective observational study
Date of disclosure of the study information 2022/03/15
Last modified on 2022/03/06 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Outcomes of continuous renal replacement therapy: a multicenter retrospective observational study
Acronym Outcomes of continuous renal replacement therapy: a multicenter retrospective observational study
Scientific Title Outcomes of continuous renal replacement therapy: a multicenter retrospective observational study
Scientific Title:Acronym Outcomes of continuous renal replacement therapy: a multicenter retrospective observational study
Region
Japan

Condition
Condition Patients requiring continuous renal replacement therapy
Classification by specialty
Intensive care medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the outcomes of continuous renal replacement therapy
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Temporal changes of blood electrolyte concentrations during continuous renal replacement therapy
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1) Patients treated by continuous renal replacement therapy from March 2021 to March 2022
2) Patients with more than one daily test 24 hours after treatment initiation
3) Patients treated with SUBPACK-Bi or Sublood-BSG
Key exclusion criteria Patients who refuse to participate in this study based on the optout
Target sample size 1000

Research contact person
Name of lead principal investigator
1st name Kent
Middle name
Last name Doi
Organization The Univerity of Tokyo
Division name Department of Emergency and Critical Care Medicine
Zip code 113-8654
Address 7-3-1, Hongo, Bunkyo-ku, Tokyo
TEL 03-3812-2111
Email kentdoi@m.u-tokyo.ac.jp

Public contact
Name of contact person
1st name Yutaro
Middle name
Last name Inoue
Organization The Univerity of Tokyo
Division name Department of Emergency and Critical Care Medicine
Zip code 113-8654
Address 7-3-1, Hongo, Bunkyo-ku, Tokyo
TEL 03-3812-2111
Homepage URL
Email inouey-eme@h.u-tokyo.ac.jp

Sponsor
Institute the University of Tokyo
Institute
Department

Funding Source
Organization Nipro corporation
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Office for Human Research Studies Graduate School of Medicine and Faculty of Medicine, The University of Tokyo
Address 7-3-1, Hongo, Bunkyo-ku, Tokyo
Tel 03-3812-2111
Email ethics@m.u-tokyo.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 03 Month 15 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2022 Year 02 Month 14 Day
Date of IRB
Anticipated trial start date
2022 Year 03 Month 15 Day
Last follow-up date
2022 Year 06 Month 15 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Others

Management information
Registered date
2022 Year 03 Month 06 Day
Last modified on
2022 Year 03 Month 06 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053718